Overview

Treatment Resistant Bipolar Depression

Status:
Terminated

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

To determine if adding Escitalopram to current mood stabilizer (MS) or atypical antipsychotic (AA) will improve in rates similar to or better than adding a placebo (inactive pill)in resistant bipolar patients.

Phase:

Phase 1

Details

Lead Sponsor:

Queen's University

Treatments:

Citalopram
Dexetimide